We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBT
1601
DELISTED
Global Blood Therapeutics, Inc.
GBT
-21,665
Closed -$759K
ATHX
1602
DELISTED
Athersys, Inc. Common Stock
ATHX
-400
Closed -$14K
MGP
1603
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
-18,602
Closed -$681K
CVA
1604
DELISTED
Covanta Holding Corporation
CVA
-106,392
Closed -$1.87M
QTS
1605
DELISTED
QTS REALTY TRUST, INC.
QTS
-3,161
Closed -$244K
MXIM
1606
DELISTED
Maxim Integrated Products
MXIM
-3,184
Closed -$335K
BPYU
1607
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
-218,265
Closed -$4.12M
BPY
1608
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
-12,981
Closed -$246K
ALXN
1609
DELISTED
Alexion Pharmaceuticals
ALXN
-2,163
Closed -$397K
HZNP
1610
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-6,500
Closed -$609K
COWN
1611
DELISTED
Cowen Inc. Class A Common Stock
COWN
-11,665
Closed -$479K
BSCM
1612
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
-17,775
Closed -$384K
AAWW
1613
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
-46,422
Closed -$3.16M
LAC
1614
DELISTED
Lithium Americas Corp. Common Shares
LAC
-17,178
Closed -$255K
GAB.RT
1615
DELISTED
The Gabelli Equity Trust Inc. Rights (expiring July 14, 2021)
GAB.RT
-44,550
Closed -$5K

Similar funds

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.